This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Canakinumab for the Prevention of Recurrences Afte...
Clinical trial

Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF

Read time: 1 mins
Last updated:5th Mar 2013
The purpose of this study is to test the efficacy of a single injection of Canakinumab on AF recurrences within 6 months after electrical cardioversion in patients with persistent AF.
Category Value
Study start date 2013-03-05

View full details